The Leukemia & Lymphoma Society

Let’s hear it for the 2025 Equity in Access Research Program grantees! 👏📣 We are proud to award nearly $5 million in research to help make blood cancer care more equitable—from diagnosis through survivorship. Meet the grantees shaping the future 👉 bit.ly/44zQn1i

76 years. One dream. One goal. A world without blood cancer.

Living with a myeloproliferative neoplasm (MPN)? This @Patient_Story discussion, led by patients, is all about tracking symptoms, advocating for better care, and finding support along the way. Secure your spot 👉 bit.ly/4lIbB4j

What is chronic lymphocytic leukemia (CLL), how is it treated, and what does care look like after a diagnosis? Dr. Marc Hoffmann from @KUcancercenter breaks it all down in our latest podcast episode—plus, what’s next in research and care 👉 bit.ly/4506BBc

Trust your gut. Ask your questions. 🎥 @/liv.it.upp on TikTok

Health equity isn’t just a goal. It’s a necessity. That’s why we launched the Equity in Access Research Program. This work is bold. It’s ambitious. And it’s exactly what blood cancer patients deserve. Hear from @DrGwenNichols, LLS Chief Medical Officer 👉 bit.ly/4lwlLF7

Progress like this is why we do what we do. The @US_FDA approved a new immune-based therapy for people with multiple myeloma. With nearly $40M invested in myeloma research, we are committed to giving patients more time and more hope 👉 bit.ly/4nS02ZS

Big feelings, small voices 🫶 “Stars Will Twinkle, the Sun Will Shine” helps kids and their families talk about blood cancer. Now, it’s an animated movie. 📽️ Watch the story unfold and share with someone who needs it 👉 bit.ly/4lRX9GD

Hey you! Yeah you! Don’t forget to be gentle with yourself ❤️

Want to be part of the next wave of LLS-funded research? 🧐 We’re proud to support work that drives progress in blood cancer care, from discovery to real-world impact. Explore open Research Grant Programs now accepting applications 👉 bit.ly/40edIEr

Don’t let the name fool you—we are here for all blood cancers, from A to Z (AML to Waldenström’s)

A new @US_FDA approved treatment is improving progression-free survival time for people with follicular lymphoma. That's more time for everyday moments, milestones, and everything in between. ❤️ More on what this means for patients 👉 bit.ly/4kvwpe2